Your browser doesn't support javascript.
loading
The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia.
François, Bruno; Chastre, Jean; Eggiman, Philippe; Laterre, Pierre-François; Torres, Antoni; Sanchez, Miguel; Esser, Mark T; Bishop, Brian; Bonten, Marc; Goosens, Herman; Jafri, Hasan S.
Afiliación
  • François B; INSERM CIC 1435, INSERM UMR 1092 and Service de Réanimation Polyvalente, CHU Dupuytren, Limoges.
  • Chastre J; Service de Réanimation Médicale, Institute of Cardiometabolism and Nutrition, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie-Paris 6, France.
  • Eggiman P; Service de Médecine Intensive Adulte et Centre des Brûlés, Département des Centres Interdisciplinaire et Logistique Médicale, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
  • Laterre PF; Service des Soins Intensifs, Cliniques Universitaires St Luc, Université Catholique de Louvain, Bruxelles, Belgium.
  • Torres A; Servei de Pneumologia, Hospital Clinic, Universitat de Barcelona, IDIBAPS CIBERES.
  • Sanchez M; Servicio de Medicina Intensiva, Hospital Clínico San Carlos, Madrid, Spain.
  • Esser MT; MedImmune, One MedImmune Way, Gaithersburg, Maryland.
  • Bishop B; MedImmune, One MedImmune Way, Gaithersburg, Maryland.
  • Bonten M; Department of Medical Microbiology and Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands.
  • Goosens H; Laboratory of Medical Microbiology, VAXINFECTIO, University of Antwerp, Belgium.
  • Jafri HS; MedImmune, One MedImmune Way, Gaithersburg, Maryland.
Clin Infect Dis ; 63 Suppl 2: S46-51, 2016 Aug 15.
Article en En | MEDLINE | ID: mdl-27481953
The Innovative Medicines Initiative-funded COMBACTE consortium fosters academic-industry partnership in pioneering studies to combat serious bacterial infections. We describe how this partnership is advancing the development of 2 monoclonal antibodies, MEDI4893 and MEDI3902, for the prevention of nosocomial pneumonia.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infección Hospitalaria / Neumonía Bacteriana / Descubrimiento de Drogas / Asociación entre el Sector Público-Privado / Antibacterianos / Anticuerpos Monoclonales Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2016 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infección Hospitalaria / Neumonía Bacteriana / Descubrimiento de Drogas / Asociación entre el Sector Público-Privado / Antibacterianos / Anticuerpos Monoclonales Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2016 Tipo del documento: Article